2010
DOI: 10.1002/hec.1686
|View full text |Cite
|
Sign up to set email alerts
|

Preferences for new and existing contraceptive products

Abstract: New contraceptive methods provide greater choice in terms of effectiveness, management of side-effects, convenience and frequency of administration and flexibility, but make the decisions about contraception more complex. There are limited data on the factors that determine women's choices among these alternatives, to inform providers about the factors which are most important to women, or to predict uptake of new products. This paper reports on a choice experiment designed to elicit women's preferences in rel… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
33
0

Year Published

2011
2011
2021
2021

Publication Types

Select...
8

Relationship

4
4

Authors

Journals

citations
Cited by 36 publications
(33 citation statements)
references
References 14 publications
0
33
0
Order By: Relevance
“…Under the assumption that individuals are rational, DCEs can approximate which choice people would make given the option in reality [9,10]. PPA is common outside of health and is increasingly being applied by health economists to predict demand for a range of health-related choices, including HIV prevention products [11], contraceptive services [12], vaccination [13], and migraine treatments [9].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Under the assumption that individuals are rational, DCEs can approximate which choice people would make given the option in reality [9,10]. PPA is common outside of health and is increasingly being applied by health economists to predict demand for a range of health-related choices, including HIV prevention products [11], contraceptive services [12], vaccination [13], and migraine treatments [9].…”
Section: Introductionmentioning
confidence: 99%
“…DCE predictions can be particularly useful for estimating the uptake of new products or services where observational data, from trials or pilot projects, are not available [12,13]. In the absence of observational data, for example in from a pragmatic trial or demonstration project, "expert opinion" is often used to generate uptake predictions, which are then commonly used to inform impact or cost-effectiveness models [14].…”
Section: Introductionmentioning
confidence: 99%
“…For example, if data are being pooled across very different subsamples of respondents, scale heterogeneity would be an obvious concern; see for example [29]. If one is simulating the impact of the introduction of a new product or treatment as in [34] then it would be prudent to avoid MNL and allow for flexible substitution patterns.…”
Section: Post Estimationmentioning
confidence: 99%
“…The first is to simply harness the first (best) choice in each choice set, ignoring the additional choice data using models outlined above in Section 2.2 (as done by [33,34]). Alternatively, the additional preference information obtained from a BWDCE can be used to estimate discrete choice models by noting that the best and worst choice questions produce an implied rank order over alternatives which can be modelled with rank ordered logit (ROL) (e.g.…”
Section: Best-worst and Best-best Discrete Choice Modelsmentioning
confidence: 99%
“…Another direction in the development of combined hormonal contraceptives is to introduce new forms of administration. Until recently, the vast majority of general public as well as some physicians could not imagine combined hormonal contraception in any form other than the daily pill [2].…”
Section: Introductionmentioning
confidence: 99%